MaxIndicationPhase being -1 in clinical trials dataset in OpenTargets Platform- what does it mean?

Hi, my first post here so apologies if it’s not the right place to post!

I played with OpenTargets data that I found here, specifically Drug - Indications dataset in a parquet format: Open Targets Platform

I find the dataset super useful but I see that for some indications (333) MaxPhaseIndication is -1? Could anyone shed some lights on what does it represent? Is it a bug or is it a feature?

Screenshot below, I needed to unnest & explode the dataframe

Thanks, would be great to get some clarification!

Hi @piotrkan, and welcome to the Open Targets Community! :tada:

This is covered in our documentation.

Essentially, -1 represents drugs for which we cannot assign a clinical phase.

Let us know if you have further questions!

1 Like